Radiology is one of the most technologically innovative medical specialties — it is in a constant state of change and evolution. As AI blazes through industries, upending how things are done and understood, radiology is not immune to AI’s sweeping impact. But, as our guest Dr. Nina Kottler, Associate Chief Medical Officer, Clinical AI at Radiology Partners, …

We live in an age with ever-advancing psychiatric treatments for mental health and addiction, yet the opioid epidemic continues to rage unabated. With all these modern tools at our disposal, why is our approach to addiction treatment still failing? Our latest guest in our 3 part Opioid Crisis Series, Dr. Michael Genovese, Chief Medical Officer …

Workers in neurocritical care have an incredibly demanding job, but — as the pandemic revealed — one that is absolutely vital in supporting societal wellbeing. But are we doing everything we can to support their wellbeing? In this episode, Dr. Sasha Yakhkind, Neurocritical Care Physician at Tufts Medical Center, joins to discuss the ongoing burnout …

The pharmaceutical industry is the least trusted by the public — and it’s not hard to see why. The rise of OxyContin and the ensuing opioid crisis is one of the greatest preventable tragedies of our times, touching almost everyone. But if we failed to prevent bad incentives from reigning supreme in the marketing of …

  Host Mike Sacopulos interviews Ted Weyn on the current landscape for locum tenens, from the perspective of the organization that is interested in using locums and the physicians who are looking at work-life alternatives. Physician leaders and healthcare administrators are familiar with the staffing problems in medicine. The lack of physicians in certain geographic regions has become …

With a perpetuating labor shortage resulting in healthcare facilities reporting continued losses year-over-year, healthcare professionals are desperate for reprieve. While there is no impending wave of new professionals to hit the workforce any time soon, the world has begun to see a wild jump in the development of AI. On this episode, we’re joined by Ken …

This is the first episode in a special three-part series on OxyContin and the opioid crisis. The next episode will be live on 4/11/23. At some point, the opioid epidemic has touched nearly everyone’s life in this country. That makes it one of the few issues that cut across every demographic and political line. The …

Headlines, studies and endless social media posts remind us that occupational burnout is more widespread than ever — but how exactly do we define burnout? And more importantly, how do we prevent it? This week we are joined by Ginny Bonner, Senior Consultant of Physician, APP and Nursing Experience, Development and Well-Being at Banner Health. Ginny defines …

One great thing about medicine in the US is the culture of innovation and entrepreneurship that can tackle some of the biggest challenges in health. The downside? Smaller markets, like pediatrics, are often overlooked in favor of bigger, more lucrative problem solving solutions. This means healthcare heroes in these smaller sectors have to step up …

    In this episode, Founder, President & Chief Executive Officer of Annovis Dr. Maria Maccecchini discusses the biological difficulties of treating cognitive diseases like Alzheimer’s, Parkinson’s and Dementia, and how two developing therapeutics may hold the key to stopping them. See all episodes